Differences were considered statistically significant if p values were less than 0.05
The pattern across all four disease areas is consistent: the groups with the highest documented disease incidence, prevalence, or mortality are the same groups most underrepresented in the trials generating the evidence base for treating that disease, a structural mismatch that FDA's own guidance explicitly names as the policy rationale for the Diversity Action Plan requirement ( [85] )
The ferroptosis signalling pathway is comprehensive, and in addition to the classical disorders of iron metabolism, the glutathionecysteamineglutathione system and polyunsaturated fatty acid metabolism, an increasing number of signalling pathways, such as nicotinamide adenine dinucleotide phosphate/ferroptosis-inhibitory protein 1 and tetrahydrobiopterin/GPT cycloheximide 1/dihydrofolate reductase, have been identified 51
Bloating, heartburn, or abdominal discomfort
For a detailed comparison of these two tissue repair peptides, see our BPC-157 vs TB-500 research guide
